menu
    • menu

    Company profile for Revolution Medicines

    NEW Drugs in Dev: 6
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on RAS and mTOR signaling pathways. We are utilizing our deep understanding of genetic drivers and adaptive resistance mechanisms in cancer, coupled with robust drug discovery and medicinal chemistry capabil...
    Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on RAS and mTOR signaling pathways. We are utilizing our deep understanding of genetic drivers and adaptive resistance mechanisms in cancer, coupled with robust drug discovery and medicinal chemistry capabilities, to build a portfolio of compounds that inhibit critical signaling nodes within the RAS and mTOR pathways.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Revolution MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Saginaw Drive Redwood City, CA 94063
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.revmed.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/revolution-medicines
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Revolution Medicines To Unveil Mutant-Targeted RAS(ON) Inhibitor
    Revolution Medicines To Unveil Mutant-Targeted RAS(ON) Inhibitor

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3278567/0/en/revolution-medicines-to-present-preclinical-data-on-innovative-mutant-targeted-catalytic-ras-on-inhibitor-at-the-2026-aacr-annual-meeting.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    Revolution Medicines To Unveil Daraxonrasib Phase 3 Results
    Revolution Medicines To Unveil Daraxonrasib Phase 3 Results

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3278211/0/en/revolution-medicines-to-present-pivotal-phase-3-rasolute-302-clinical-trial-results-for-daraxonrasib-in-previously-treated-metastatic-pancreatic-cancer-during-a-plenary-session-at-.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    Revolution Medicines Presents Daraxonrasib in First-Line at 2026
    Revolution Medicines Presents Daraxonrasib in First-Line at 2026

    21 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/21/3278575/0/en/revolution-medicines-to-present-updated-phase-1-2-clinical-data-for-daraxonrasib-in-first-line-metastatic-pancreatic-cancer-across-monotherapy-and-combination-cohorts-at-the-2026-a.html

    GLOBENEWSWIRE
    21 Apr 2026
    Share Share
    Revolution to Present Updated Ph 1 Clinical Data for Zoldonrasib
    Revolution to Present Updated Ph 1 Clinical Data for Zoldonrasib

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187986

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Revolution Medicines Leads $1.5B Stock Offering Wave
    Revolution Medicines Leads $1.5B Stock Offering Wave

    14 Apr 2026

    // ENDPOINTS

    https://endpoints.news/revolution-medicines-leads-latest-wave-of-stock-offerings-totaling-1-5b/

    ENDPOINTS
    14 Apr 2026
    Share Share
    Revolution Medicines to Offer Stock and Convertible Senior Notes
    Revolution Medicines to Offer Stock and Convertible Senior Notes

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272883/0/en/Revolution-Medicines-Inc-Announces-Proposed-Offerings-of-Common-Stock-and-Convertible-Senior-Notes.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search